We investigated the alterations in the stable end products of nitric oxide, i.e., nitrate and nitrite, in the plasma during and after rat focal cerebral ischemia by an automated procedure based on the Griess reaction. At 2 h of middle cerebral artery (MCA) occlusion, plasma ni trate/nitrite levels were significantly higher (53 ± 8 ILM, mean ± SD, n = 5, p < 0.05) than in rats with sham operation (36 ± 9 ILM, n = 5), and were mildly elevated at 4 h of MCA occlusion (42 ± 9 ILM, n = 5, n.s.). At 30 min of reperfusion after 2 h of MCA occlusion, plasma nitrate/nitrite levels were more markedly elevated (72 ± 7 ILM, n = 5, p < 0.01 vs. sham operation), but were mod erately elevated at 2 h of reperfusion after 2 h of MCA occlusion (61 ± 10 ILM, n = 5, p < 0.05). Plasma nitrite Abbreviations used: ANOVA, analysis of variance; L-NAME, �-nitro-L-arginine methyl ester; MeA, middle cerebral artery; NOS, nitric oxide synthase.
Since Green et ai. found that mammals excrete more nitrate than dietary intake, biosynthesis of ni tric oxide is now well recognized (Green et aI., 1981; Wagner et aI., 1983; Stuher and Marietta, 1985 ; Kosaka et aI., 1992) . In animals, nitric oxide is synthesized from L-arginine by an enzymatic re action of nitric oxide synthase (NOS), which is dis tributed in neurons, perivascular nerves within the brain, and endothelial cells (Moncada et aI., 1989 ; Garthwaite et aI., 1989; Bredt and Snyder, 1990) .
To date, nitric oxide is considered both a free rad ical, an endothelium-derived relaxing factor, and a neurotransmitter (Palmer et aI., 1987; Garthwaite, 1991) . In view of the fact that NOS is distributed within the brain, nitric oxide could be deeply in volved in the pathophysiology of cerebral ischemia levels were not changed during these experimental peri ods. Administration of 20 mg/kg of NG-nitro-L-arginine methyl ester (L-NAME) significantly decreased plasma nitrate/nitrite as well as nitrite at 30 min of reperfusion after 2 h of MCA occlusion (n = 5), but 2 mg/kg of L-NAME did not (n = 3). The effect of 20 mg/kg of L-NAME on plasma nitric oxide end products was re versed by the simultaneous administration of 200 mg/kg of L-arginine (n = 3), but not D-arginine (n = 3). The present study suggests that the L-arginine-nitric oxide pathway is activated during acute cerebral ischemia and reperfusion. Key Words: Nitric oxide-Nitrate-Nitrite Cerebral ischemia. and reperfusion. Because nitric oxide decomposes within seconds into nitrite and nitrate in blood containing tissues, we determined the levels of those stable end products in the plasma during and after experimental focal cerebral ischemia in rats.
So far, there are no experimental data concerning the ischemia-related alterations in those plasma ni tric oxide degradation products.
MATERIALS AND METHODS
The basal levels of plasma nitrate and nitrite may de pend on the amount of intake of nitrogen compounds and on the anaerobic bacterial flora within the intestine (Hong et al., 1980; Green et al., 1981) . We, therefore, used spe cific pathogen-free male Sprague-Dawley rats purchased from the same feeder and fed by the same standard food and water. Forty-four rats (9 weeks old, body weight 300-3lO g) were anesthetized with intraperitoneal ketamine hydrochloride (75 mg/kg). The right femoral artery was cannulated for continuous monitoring of blood pressure and arterial blood gases. The left middle cerebral artery (MCA) was occluded by a Mayfield miniature clip via the retro-orbital approach (Tamura et al., 1981) . Leftjugular venous blood (1 m!) was collected with a heparinized syringe from animals with 2 h (n = 5) or 4 h (n = 5) of MCA occlusion and from animals without surgery (nor mal control, n = 5) and with 4 h after sham operation (n = 5). The same procedure was done in animals at 30 min (n = 5) or 2 h (n = 5) of reperfusion after 2 h of MCA occlusion. A NOS inhibitor, �-nitro-L-arginine methyl ester (L-NAME), 1 mg/kg (n = 3) or 10 mg/kg (n = 5) was administered intraperitoneally twice, at 30 min before and 1 h after arterial occlusion. In the remaining animals, 100 mg/kg of L-arginine (n = 3) or o-arginine (n = 3) was administered twice together with 10 mg/kg Of L-NAME at 30 min before and 1 h after arterial occlusion. Rats were killed at 30 min of reperfusion after 2 h of MCA occlusion. The rectal temperature of the animals was kept between 36.5 and 37°C. Arterial blood gases were analyzed at 5 min before arterial occlusion and 5 min before killing.
Within 30 s after the heparinized blood collection, the blood was centrifuged for 5 min at 1,200 g and the plasma fraction was diluted 1: 1 with nitrite/nitrate-free distilled water. Subsequently, 400 J-ll of diluted plasma was cen trifuged at 2,000 g with a micropore filter (Ultrafree MC microcentrifuge device, UFC3, Millipore, MA, U.S.A.) to remove substances larger than 10 kDa. The filtrates were analyzed with an automated procedure based on the Griess reaction (Green et aI., 1982) . Briefly, nitrite of the samples was measured by absorbance at 540 nm when mixed with the Griess reagent, consisting of 0.1 % of naphthyl ethylenediamine dihydrochloride in distilled water and 1 % sulfanilamide in 5% H3P04. Absorbance at 540 nm was also measured after passing the samples through a copper-plated cadmium column for nitrate re duction; this value expressed the total amount of plasma nitric oxide end products, nitrate plus nitrite (nitrate/ nitrite).
Physiologic data in experimental groups were analyzed by one-way analysis of variance (ANOV A), and statisti cal differences between groups at the same time points were determined by Scheffe's multiple comparison test. Statistical differences of the data with animals treated in the same way were examined with one-factor repeated measures ANOV A. An unpaired two-tailed Student t test was used to compare the mean values of plasma nitrate/ nitrite and nitrite; p < 0.05 was considered statistically significant.
RESULTS
There were no apparent intergroup differences for rectal temperature, mean arterial blood pres sure, arterial pH, Paco2, Paoz, and hematocrit either at 5 min before arterial occlusion or before killing ( Table I ). The first administration of 1 mg/kg of L-NAME at 30 min before MeA occlusion did not affect the arterial blood pressure (100 ± 10 and 108 ± 4 mm Hg, before and after administration, re spectively, mean ± SD). On the other hand, the first administration of 10 mg/kg of L-NAME signif icantly elevated mean arterial blood pressure from 106 ± 4 to 133 ± 11 mm Hg (p < 0.05). The arterial blood pressure was also elevated significantly by L-NAME (10 mg/kg) together with D-arginine (100 mg/kg) (from 93 ± 4 to 125 ± 4 mm Hg, p < 0.01), but not with L-arginine (100 mg/kg) (from 98 ± 9 to 104 ± 10 mm Hg). Upon the second administration L-NAME, �-nitro-L-arginine methyl ester.
a p < 0.05, MABP increased significantly after 25 min of the first administration of L-NAME (1 0 mg/kg) by one-factor repeated measures ANOV A.
b P < 0.01, MABP increased significantly after 25 min of the first administration of L-NAME (1 0 mg/kg) with D-arginine (1 00 mg/kg) by one-factor repeated-measures ANOV A.
at 1 h after MCA occlusion, none of those agents affected the arterial blood pressure.
Plasma nitrate/nitrite levels of normal control an imals were 33 ± 2 fJ-M and 36 ± 9 fJ-M at 4 h after sham operation. Plasma nitrite was 8 ± 1 fLM in the normal control animals and 10 ± 1 fJ-M at 4 h after sham operation. As shown in Table 2 , the plasma nitrate/nitrite levels in the jugular blood at 2 h of MCA occlusion were significantly higher than those with sham operation. The increase was, however, not significant at 4 h of MCA occlusion. On the other hand, the plasma nitrate/nitrite levels at 30 min of reperfusion after 2 h of MCA occlusion were significantly higher than those at 2 h of MCA occlu sion. Plasma nitrite levels were not changed during these experimental periods.
In animals with 30 min of reperfusion after 2 h of MCA occlusion, administration of a total of 2 mg/kg of L-NAME did not decrease the plasma nitrate/ nitrite or nitrite levels, but 20 mg/kg of L-NAME significantly decreased them. In the same model, 20 mg/kg of L-NAME with 200 mg/kg of L-arginine did not decrease plasma nitrate/nitrite or nitrite levels, whereas the same amounts of L-NAME with D-ar ginine significantly decreased them.
At 2 h of reperfusion after 2 h of MCA occlusion, the plasma nitrate/nitrite levels were lower than those at 30 min reperfusion, but were still higher than those with sham operation and at 4 h of MCA occlusion. The plasma nitrite levels remained un changed at this period.
DISCUSSION
To our knowledge, this is the first report that demonstrates the increased nitric oxide end prod ucts in the plasma during acute focal cerebral isch emia and reperfusion. The elevation of plasma ni trate/nitrite at 2 h of MCA occlusion may suggest the increased synthesis of nitric oxide, which could explain the cerebral vasodilatation during the early period of ischemia (Pelligrino et aI., 1993) . At 4 h of MCA occlusion, the plasma nitrate/nitrite levels re turned to those of the sham-operated animals, pos sibly because of a decreased supply of oxygen and L-arginine during the sustained period of ischemia (Leone et aI., 1991; Matheis et aI., 1992) . The fur ther increase in the plasma nitrate/nitrite at 30 min of reperfusion after 2 h MCA occlusion can be ex plained by the resupply of oxygen and L-arginine and due to the activation of constitutive NOS by intracellular calcium elevation during reperfusion (Nowicki et aI., 1991; Garthwaite, 1991; Matheis et aI., 1992) . (1992) reported that the plasma level of nitrosothiols in human was as high as 7 fJ-M.
A NOS inhibitor, L-NAME, decreased both ni trate/nitrite and nitrite at a dose of 20 mg/kg but not at a dose of 2 mg/kg. This dose dependency of L-NAME could be one of the explanations for the conflicting results of NOS inhibitors on the isch emic cerebral damage (Nowicki et aI. , 1991; Tanaka et aI. , 1991; Nagafuji et aI., 1992; Yamamoto et aI. , 1992) . The suppression of plasma nitric oxide end products by 20 mg/kg of L-NAME was reversed in the animals with simultaneous administration of an adequate dose of L-arginine, but not with the same dose of D-arginine. These results clearly indicate that the increased plasma nitric oxide end products are related to the increased NOS activity during acute focal cerebral ischemia and reperfusion.
In cerebral ischemia, superoxide generation after reperfusion seems to facilitate the formation of per oxynitrite. Peroxynitrite is reported to be converted to cytotoxic intermediates (Koppenol et aI. , 1992) , which may aggravate ischemic damage. On the other hand, nitric oxide inhibits platelet aggregation as well as neutrophil adhesion to endothelium, which may protect against the microcirculatory de rangement during cerebral ischemia (Radomski et aI, 1987; Yoshimine et aI. , 1989; Kubes et aI. , 1991) .
Thus the increased level of plasma nitric oxide end products can be related to either deteriorative or ameliorative processes in the ischemic brain. These issues remain the subject for further investigation.
